| abstract |
The present invention provides a diagnostic marker that can accurately detect multiple sclerosis and can predict the onset of multiple sclerosis. A diagnostic marker for detecting or predicting multiple sclerosis characterized by being an S100A9 protein. The biological sample in which the diagnostic marker is present is the subject's blood, serum, plasma, cerebrospinal fluid, urine or saliva. In particular, according to the present invention, since the onset of multiple sclerosis can be predicted, it is possible to take measures such as delaying the onset and making a treatment plan. [Selection] Figure 3 |